APDCA: An accurate and effective method for predicting associations between RBPs and AS-events during epithelial-mesenchymal transition.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41196940.
- Also identified by DOI 10.1371/journal.pcbi.1013665 and PMC identifier 12604773.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Epithelial-mesenchymal transition (EMT) plays a key role in cancer metastasis by promoting changes in adhesion and motility. RNA-binding proteins (RBPs) regulate alternative splicing (AS) during EMT, enabling a single gene to produce multiple protein isoforms that affect tumor progression. Disruption of RBP-AS interactions may disrupt the progress of diseases like cancer. Despite the importance of RBP-AS relationships in EMT, few computational methods predict these associations. Existing models struggle in sparse settings with limited known associations. To improve performance, we incorporate both sparsity constraints and heterogeneous biological data to infer RBP-AS associations. We propose a new method based on Accelerated Proximal DC Algorithm (APDCA) for predicting RBP-AS associations. In particular, APDCA combines sparse low-rank matrix factorization with a Difference-of-Convex (DC) optimization framework and uses extrapolation to improve convergence. A key feature of APDCA is the use of a sparsity constraint, which filters out noise and highlights key associations. In addition, integrating multiple related data sources with direct or indirect relationships can help in reaching a more comprehensive view of RBPs and AS events and to reduce the impact of false positives associated with individual data sources. we prove that our proposed algorithm is convergent under some conditions and the experimental results have illustrated that APDCA outperforms six baseline methods in both AUC and AUPR. A case study on the RBP QKI shows that the top predictions are verified by the OncoSplicing database. Thus, APDCA provides a fast, interpretable, and scalable tool for discovering post-transcriptional regulatory interactions.
Medical subject headings
- Epithelial-Mesenchymal Transition
- RNA-Binding Proteins
- Computational Biology
- Alternative Splicing